Seoyeon Min

481 total citations
10 papers, 248 citations indexed

About

Seoyeon Min is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Seoyeon Min has authored 10 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 2 papers in Molecular Biology. Recurrent topics in Seoyeon Min's work include Cell death mechanisms and regulation (2 papers), Cancer Genomics and Diagnostics (2 papers) and Genetic factors in colorectal cancer (2 papers). Seoyeon Min is often cited by papers focused on Cell death mechanisms and regulation (2 papers), Cancer Genomics and Diagnostics (2 papers) and Genetic factors in colorectal cancer (2 papers). Seoyeon Min collaborates with scholars based in South Korea, United States and Ethiopia. Seoyeon Min's co-authors include Charles Lee, Sung‐Yup Cho, Jinjoo Kang, Hansoo Park, Ahra Lee, Wonyoung Kang, Jee Yun Han, Jee Young Kwon, Namhyun Chung and Young Hoon Joo and has published in prestigious journals such as Oncogene, Journal of Agricultural and Food Chemistry and Clinical Cancer Research.

In The Last Decade

Seoyeon Min

10 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seoyeon Min South Korea	8	88	85	52	34	34	10	248
Prashanthi Ramesh Netherlands	7	120 1.4×	191 2.2×	60 1.2×	27 0.8×	17 0.5×	11	304
Joshua Goyert United States	4	62 0.7×	205 2.4×	51 1.0×	16 0.5×	33 1.0×	8	315
Sourya Bhattacharya India	7	92 1.0×	220 2.6×	80 1.5×	19 0.6×	21 0.6×	10	358
Yanyan Zhang China	9	93 1.1×	127 1.5×	36 0.7×	15 0.4×	67 2.0×	39	351
Anusha Thadi United States	6	82 0.9×	116 1.4×	62 1.2×	18 0.5×	11 0.3×	14	303
Olamide Animasahun United States	6	117 1.3×	249 2.9×	111 2.1×	54 1.6×	28 0.8×	9	384
Kailiang Zhao China	10	117 1.3×	182 2.1×	73 1.4×	28 0.8×	13 0.4×	38	354
Jeffrey Koury United States	6	128 1.5×	143 1.7×	37 0.7×	29 0.9×	13 0.4×	9	332
David J. Monsma United States	14	145 1.6×	188 2.2×	100 1.9×	26 0.8×	49 1.4×	17	392

Countries citing papers authored by Seoyeon Min

Since Specialization

Citations

This map shows the geographic impact of Seoyeon Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seoyeon Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seoyeon Min more than expected).

Fields of papers citing papers by Seoyeon Min

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seoyeon Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seoyeon Min. The network helps show where Seoyeon Min may publish in the future.

Co-authorship network of co-authors of Seoyeon Min

This figure shows the co-authorship network connecting the top 25 collaborators of Seoyeon Min. A scholar is included among the top collaborators of Seoyeon Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seoyeon Min. Seoyeon Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Choi, Yoo‐mi, Deukchae Na, Jisoo Kim, et al.. (2025). Prediction of Patient Drug Response via 3D Bioprinted Gastric Cancer Model Utilized Patient‐Derived Tissue Laden Tissue‐Specific Bioink. Advanced Science. 12(10). e2411769–e2411769. 7 indexed citations

Min, Seoyeon, et al.. (2022). Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid. The Journal of Dermatology. 50(5). 705–709. 4 indexed citations

Jung, Hae Rim, Yumi Oh, Deukchae Na, et al.. (2021). CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers. Oncogene. 40(18). 3287–3302. 21 indexed citations

Oh, Yumi, Hae Rim Jung, Seoyeon Min, et al.. (2020). Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers. Cancer Letters. 497. 123–136. 13 indexed citations

Cho, Sung‐Yup, Jeesoo Chae, Deukchae Na, et al.. (2019). Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers. Clinical Cancer Research. 25(9). 2821–2834. 13 indexed citations

Min, Seoyeon, et al.. (2018). 16S rDNA microbiome composition pattern analysis as a diagnostic biomarker for biliary tract cancer. HPB. 20. S312–S312. 3 indexed citations

Cho, Sung‐Yup, Jee Yun Han, Deukchae Na, et al.. (2017). A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF -mutated and BCL2L1 -amplified Colorectal Cancers. Molecular Cancer Therapeutics. 16(10). 2178–2190. 12 indexed citations

Kim, Young Tae, Youngchul Kim, Minji Choi, et al.. (2017). Grape seed proanthocyanidin inhibits inflammatory responses in hepatic stellate cells by modulating the MAPK, Akt and NF-κB signaling pathways. International Journal of Molecular Medicine. 40(1). 226–234. 20 indexed citations

Kim, Young Il, Chang‐Nim Im, Sung Wan Kim, et al.. (2017). Grape Seed Proanthocyanidin Inhibits Mucin Synthesis and Viral Replication by Suppression of AP-1 and NF-κB via p38 MAPKs/JNK Signaling Pathways in Respiratory Syncytial Virus-Infected A549 Cells. Journal of Agricultural and Food Chemistry. 65(22). 4472–4483. 45 indexed citations

10.

Cho, Sung‐Yup, Wonyoung Kang, Jee Yun Han, et al.. (2016). An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts. Molecules and Cells. 39(2). 77–86. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact